The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Theraputics Inc. (ACRS) | COM | 00461U105 | 6,842,666 | 434,455 | SH | SOLE | 434,455 | 0 | 0 | |||
| Aeglea Biotherapeutics Inc. (AGLE) | COM | 00773J103 | 761,018 | 1,691,151 | SH | SOLE | 1,691,151 | 0 | 0 | |||
| Atreca Inc. (BCEL) | CL A COM | 04965G109 | 310,510 | 387,653 | SH | SOLE | 387,653 | 0 | 0 | |||
| AVROBIO, Inc. (AVRO) | COM | 05455M100 | 716,943 | 1,009,779 | SH | SOLE | 1,009,779 | 0 | 0 | |||
| Biomea Fusion Inc. (BMEA) | COM | 09077A106 | 6,733,522 | 798,757 | SH | SOLE | 798,757 | 0 | 0 | |||
| BridgeBio Pharma Inc. (BBIO) | COM | 10806X102 | 46,239,113 | 6,068,125 | SH | SOLE | 6,068,125 | 0 | 0 | |||
| Elevation Oncology Inc. (ELEV) | COM | 28623U101 | 2,693,165 | 2,834,910 | SH | SOLE | 2,834,910 | 0 | 0 | |||
| Marker Therapeutics, Inc. (MRKR) | COM | 57055L107 | 848,571 | 3,142,857 | SH | SOLE | 3,142,857 | 0 | 0 | |||
| Monte Rosa Therapeutics Inc. (GLUE) | COM | 61225M102 | 11,204,439 | 1,472,331 | SH | SOLE | 1,472,331 | 0 | 0 | |||
| Nuvation Bio Inc. (NUVB) | COM CL A | 67080N101 | 4,878,737 | 2,541,009 | SH | SOLE | 2,541,009 | 0 | 0 | |||
| Poseida Therapeutics Inc. (PSTX) | COM | 73730P108 | 5,529,315 | 1,043,267 | SH | SOLE | 1,043,267 | 0 | 0 | |||
| Viracta Therapeutics Inc. (VIRX) | COM | 92765F108 | 421,314 | 288,571 | SH | SOLE | 288,571 | 0 | 0 | |||
| Verona Pharma plc (VRNA) | SPONSORED ADS | 925050106 | 34,817,833 | 1,332,485 | SH | SOLE | 1,332,485 | 0 | 0 | |||
| Reneo Pharmaceuticals Inc. (RPHM) | COM | 75974E103 | 2,064,555 | 886,075 | SH | SOLE | 886,075 | 0 | 0 | |||
| Syndax Pharmaceuticals, Inc. (SNDX) | COM | 87164F105 | 26,086,250 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | |||
| Spruce Biosciences, Inc. (SPRB) | COM | 85209E109 | 1,322,446 | 1,205,511 | SH | SOLE | 1,205,511 | 0 | 0 | |||